Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

TRACON Pharmaceuticals (TCON)

TRACON Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TCON
DateTimeSourceHeadlineSymbolCompany
13/05/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
07/03/202422:03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TCONTRACON Pharmaceuticals Inc
05/03/202422:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TCONTRACON Pharmaceuticals Inc
28/02/202421:02GlobeNewswire Inc.TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024NASDAQ:TCONTRACON Pharmaceuticals Inc
14/02/202421:31Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCONTRACON Pharmaceuticals Inc
09/02/202421:05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TCONTRACON Pharmaceuticals Inc
19/12/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
08/12/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
20/11/202313:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
09/11/202322:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCONTRACON Pharmaceuticals Inc
06/10/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
18/09/202313:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
07/09/202321:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
14/08/202322:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCONTRACON Pharmaceuticals Inc
14/08/202321:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
07/08/202322:02Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TCONTRACON Pharmaceuticals Inc
25/07/202322:19Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TCONTRACON Pharmaceuticals Inc
11/07/202313:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
20/06/202313:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCONTRACON Pharmaceuticals Inc
15/06/202313:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCONTRACON Pharmaceuticals Inc
09/06/202322:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCONTRACON Pharmaceuticals Inc
02/06/202322:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCONTRACON Pharmaceuticals Inc
02/06/202321:47Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TCONTRACON Pharmaceuticals Inc
01/06/202311:06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TCONTRACON Pharmaceuticals Inc
31/05/202321:22Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:TCONTRACON Pharmaceuticals Inc
19/05/202322:02Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:TCONTRACON Pharmaceuticals Inc
10/05/202321:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCONTRACON Pharmaceuticals Inc
03/05/202321:02GlobeNewswire Inc.TRACON to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 10, 2023NASDAQ:TCONTRACON Pharmaceuticals Inc
28/04/202311:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCONTRACON Pharmaceuticals Inc
25/04/202312:49Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCONTRACON Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TCON

Your Recent History

Delayed Upgrade Clock